No-fee pass countdown: 5 days! Dr. Liu Zhenyun, founder of Yixi Bio, confirmed to attend the Yimao Bio-Manufacturing Conference!

Recently, with the rapid advancement of synthetic biology and sustained policy support, biomanufacturing is emerging as a core track in the new round of technological revolution.

However, inHuman Milk OligosaccharidesHuman Milk Oligosaccharides (HMOs) have long faced a critical challenge: while HMOs, the third-largest solid component in breast milk, play an irreplaceable role in regulating infant gut microbiota and establishing immune systems, their core production technology has been monopolized by international giants such as DSM (Netherlands) and Chr. Hansen (Denmark). As a result, domestic infant formula manufacturers remain heavily reliant on imported raw materials, driving up product costs and creating a strategic vulnerability in the supply chain.

Achieving a full-chain breakthrough—from strain construction and fermentation processes to green extraction, large-scale industrialization, and global supply chain deployment—remains the most critical challenge facing China's synthetic biology industry.

Against this backdrop,2026 (2nd) Yimao Bio-Manufacturing Industry Conference & Exhibition (Summer) will be held in Shanghai from 8 to 28.At the exhibition, we will invite2000+Attendee,100+Speaker,20+Premium exhibitors, featuring "Conference - Exhibition - Meeting - EventFour core modules focused on "fundamental research breakthroughs + cross-domain industrial implementation," providing comprehensive coverage.Medical aesthetics, bio-based materials, green chemicals, food, agriculture, AI-enabledSix core domains driving deep collaboration among top research experts, industry leaders, innovative SMEs, investment firms, and upstream/downstream supply chains to create the premier biomanufacturing ecosystem showcase.

All-category registration for this exhibition is now open. The no-barrier pass countdown is 5 days!Scan the QR code to view ticket types and benefits, then choose the plan that best fits you. Register now for instant review. Early registration secures limited spots and unlocks exclusive access to exhibitions, forums, and more.

This conference is especially pleased to inviteDr. Liu Zhenyun, Founder and CEO of Yixi BioShowcasing cutting-edge synthetic biology research and technological expertise. Connect deeply with industry peers. Stay tuned!

Dr. Liu ZhenyunHolds a bachelor's and Ph.D. from Peking University; expert in synthetic biology. Founder and CEO of Suzhou Yixi Biotechnology Co., Ltd., specializing in biochemistry and molecular biology. Dedicated to advancing the biopharmaceutical and nutrition health industries through technological innovation.

Yixi BioFounded in 2019, headquartered at Suzhou Industrial Park, Jiangsu Province.Focusing on technological innovation and breakthroughs in synthetic biology.The company leverages food additives as a strategic entry point to build R&D pipelines—including HMO biosynthesis—driven by foundational innovations that expand the boundaries of human food sources.

In terms of production capacity and supply chain, Yixi Bio's wholly-owned subsidiary Huangshan Tongxi Biotechnology Co., Ltd. has been established.The world's largest single-plant facility for human milk oligosaccharide (HMO) monomers, with an annual production capacity of 3500 tons. Our HMO products have simultaneously received GRAS certification from the U.S. FDA, Novel Food authorization from the European Union, and approval from China's National Health Commission, making us one of the few global HMO companies to hold triple authority certifications across the U.S., EU, and China. Our products are exported to over 30 countries and regions, and we have established deep partnerships with leading dairy companies both domestically and internationally.

In food security and biomanufacturing, Yixi Bio innovatively uses straw as a non-food carbon source to successfully develop an efficient technology for synthesizing microbial protein for animal feed.This technology has completed pilot validation and is scheduled to officially launch industrialization in 2026, with the construction of a demonstration plant. Through technological innovation and biomanufacturing, we aim to support national food security.

Dr. Liu Zhenyun's talk will directly address industry pain points, delivering replicable and actionable Chinese solutions for bio-manufacturing, nutrition and health, maternal and infant foods, and medical foods.

At the same time, this exhibition brings together the core strength of the entire biomanufacturing industry chain, featuring leaders from top-tier enterprises, academic pioneers from leading universities, authoritative experts from national research institutes, and key representatives of global industry think tanks. An all-star lineup with unmatched prestige!

2026 (2nd) EMBC Bio-Manufacturing Industry Conference & Exhibition (Summer)

2026 (2nd) Yimao Bio-Manufacturing Industry Conference & Exhibition (Summer) will be held in Shanghai from 8 to 28.At the exhibition, we will invite2000+Attendee,100+Speaker,20+Premium exhibitors, featuring "Conference - Exhibition - Meeting - EventFour core modules focused on "breakthroughs in fundamental research + cross-domain industrial implementation."

Whether you are an entrepreneur, investor, technical expert, or procurement decision-maker in the bio-manufacturing sector, this exhibition offers a platform to explore the latest policy trends and industry developments, connect with top-tier capital and high-quality projects, and showcase cutting-edge technologies and innovative products.